Variant report

Variant	nsv1026893
Chromosome Location	chr6:162267755-162654151
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:43)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:43 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162525404..162526979-chr6:162529518..162531928,2	MCF-7	breast:
2	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
3	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
4	chr6:162552000..162556573-chr6:162556763..162561114,5	K562	blood:
5	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
6	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
7	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
8	chr6:162552000..162556573-chr6:162556763..162561114,5	K562	blood:
9	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
10	chr6:162258059..162258779-chr6:162552660..162553528,2	MCF-7	breast:
11	chr6:162553757..162556831-chr6:162558713..162560436,3	K562	blood:
12	chr6:162500411..162502828-chr6:162504694..162507642,2	K562	blood:
13	chr6:162574333..162576032-chr6:162578404..162580150,2	K562	blood:
14	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
15	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
16	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
17	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
18	chr6:162436271..162438282-chr6:162512437..162514970,2	K562	blood:
19	chr6:162258117..162258784-chr6:162338530..162339165,2	MCF-7	breast:
20	chr3:66689243..66689865-chr6:162514238..162514739,2	MCF-7	breast:
21	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
22	chr6:162525404..162526979-chr6:162529518..162531928,2	MCF-7	breast:
23	chr6:162470841..162473078-chr6:162475586..162477804,2	MCF-7	breast:
24	chr6:162313026..162315357-chr6:162317264..162319780,2	K562	blood:
25	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
26	chr6:162347118..162349182-chr6:162351860..162355211,3	K562	blood:
27	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
28	chr6:162500411..162502828-chr6:162504694..162507642,2	K562	blood:
29	chr6:162470841..162473078-chr6:162475586..162477804,2	MCF-7	breast:
30	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
31	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
32	chr6:162313026..162315357-chr6:162317264..162319780,2	K562	blood:
33	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
34	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
35	chr6:162436271..162438282-chr6:162512437..162514970,2	K562	blood:
36	chr6:162574333..162576032-chr6:162578404..162580150,2	K562	blood:
37	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
38	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
39	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
40	chr6:162553757..162556831-chr6:162558713..162560436,3	K562	blood:
41	chr6:162347118..162349182-chr6:162351860..162355211,3	K562	blood:
42	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
43	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:

No data

Extended variants
information (count: 14432 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:14432 , 50 per page) page: 1 2 3 4 5 6 7 ... 289

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566910579	chr6:162267799-162267800	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs375653884	chr6:162267804-162267805	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs532508898	chr6:162267836-162267837	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs552679300	chr6:162267872-162267873	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs569104401	chr6:162267987-162267988	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs538076256	chr6:162268005-162268006	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs144483587	chr6:162268081-162268082	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs60218884	chr6:162268087-162268088	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs533751979	chr6:162268124-162268125	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs369925769	chr6:162268137-162268138	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs553488296	chr6:162268146-162268147	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs576815775	chr6:162268156-162268157	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs191656240	chr6:162268168-162268169	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs556324578	chr6:162268196-162268197	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs576290900	chr6:162268209-162268210	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs541572307	chr6:162268270-162268271	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs542062741	chr6:162268274-162268275	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs116856201	chr6:162268288-162268289	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs527594214	chr6:162268296-162268297	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs540580241	chr6:162268393-162268394	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs560277131	chr6:162268434-162268435	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs9456715	chr6:162268469-162268470	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs373500627	chr6:162268482-162268483	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs184617618	chr6:162268516-162268517	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs552229165	chr6:162268527-162268528	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs142920063	chr6:162268589-162268590	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs11395343	chr6:162268625-162268626	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs397720898	chr6:162268636-162268637	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs146159678	chr6:162268712-162268713	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs563145924	chr6:162268723-162268724	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs548393064	chr6:162268749-162268750	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs377438258	chr6:162268816-162268817	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs575394872	chr6:162268933-162268934	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559694778	chr6:162268961-162268962	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs140155926	chr6:162268995-162268996	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs534219635	chr6:162269009-162269010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs141693605	chr6:162269018-162269019	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs549251759	chr6:162269028-162269029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs570332750	chr6:162269072-162269073	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs539455577	chr6:162269076-162269077	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs556261290	chr6:162269135-162269136	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs189181665	chr6:162269142-162269143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs535598655	chr6:162269151-162269152	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs555610202	chr6:162269153-162269154	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs572244911	chr6:162269163-162269164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs151257930	chr6:162269200-162269201	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs561064655	chr6:162269264-162269265	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs564432221	chr6:162269267-162269268	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs577151918	chr6:162269332-162269333	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs564596211	chr6:162269378-162269379	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD
early-passage human iPS cells	21368824	CNVD
Parkinson disease	21829596	CNVD
Gastric cancer	22315472	CNVD
Autism	19404257	CNVD
Schizophrenia	21346763	CNVD

Chromatin state (count:1172 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162261200-162268800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr6:162268800-162269000	Enhancers	ES-I3 Cell Line	embryonic stem cell
3	chr6:162268800-162269200	Enhancers	Liver	Liver
4	chr6:162269000-162269200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr6:162269000-162271600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr6:162269800-162270000	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr6:162269800-162270000	Enhancers	iPS-20b Cell Line	embryonic stem cell
8	chr6:162270000-162271800	Weak transcription	HUES64 Cell Line	embryonic stem cell
9	chr6:162270000-162271800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
10	chr6:162271200-162271400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr6:162271600-162272000	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr6:162271800-162272200	Enhancers	H1 Cell Line	embryonic stem cell
13	chr6:162271800-162272200	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr6:162271800-162272200	Enhancers	iPS-15b Cell Line	embryonic stem cell
15	chr6:162271800-162272200	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr6:162271800-162272400	Enhancers	HUES64 Cell Line	embryonic stem cell
17	chr6:162271800-162272400	Enhancers	iPS-20b Cell Line	embryonic stem cell
18	chr6:162272000-162272200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
19	chr6:162272000-162272200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr6:162272200-162278200	Weak transcription	HUES48 Cell Line	embryonic stem cell
21	chr6:162273800-162275000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr6:162273800-162275200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr6:162278200-162278400	Weak transcription	HUES64 Cell Line	embryonic stem cell
24	chr6:162278200-162278600	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr6:162278200-162279200	Enhancers	iPS-18 Cell Line	embryonic stem cell
26	chr6:162278400-162278800	Enhancers	H9 Cell Line	embryonic stem cell
27	chr6:162278400-162279800	Enhancers	H1 Cell Line	embryonic stem cell
28	chr6:162278400-162279800	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr6:162278400-162279800	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr6:162278600-162279400	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr6:162278800-162279200	Weak transcription	H9 Cell Line	embryonic stem cell
32	chr6:162279200-162279800	Enhancers	H9 Cell Line	embryonic stem cell
33	chr6:162279200-162283200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
34	chr6:162279400-162279600	Enhancers	HUES48 Cell Line	embryonic stem cell
35	chr6:162279400-162279800	Enhancers	ES-I3 Cell Line	embryonic stem cell
36	chr6:162279400-162279800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr6:162279800-162283000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
38	chr6:162282600-162284200	Enhancers	Cortex derived primary cultured neurospheres	brain
39	chr6:162282800-162284000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
40	chr6:162283000-162283800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr6:162283200-162283800	Enhancers	iPS-18 Cell Line	embryonic stem cell
42	chr6:162283600-162284000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr6:162284000-162291200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
44	chr6:162286200-162286400	Enhancers	Stomach Mucosa	stomach
45	chr6:162286400-162290600	Weak transcription	Stomach Mucosa	stomach
46	chr6:162287600-162288200	Enhancers	Duodenum Mucosa	Duodenum
47	chr6:162287800-162288600	Enhancers	Rectal Mucosa Donor 31	rectum
48	chr6:162288200-162290600	Weak transcription	Duodenum Mucosa	Duodenum
49	chr6:162290400-162291000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
50	chr6:162290600-162291400	Enhancers	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links